STING Inhibitor MJFF
AeroNeph Therapeutics, Inc. Nominates a Hit-to-Lead STING Inhibitor Small Molecule for In Vivo Studies Focused on Parkinson’s Disease and for Further Development in Autoinflammatory and Autoimmune Disease Indications In studies begun by DiscoveryBioMed, Inc. in collaboration with Nitor Therapeutics, Inc. (Birmingham, AL) and funded by a Phase 1 SBIR grant award, AeroNeph Therapeutics, Inc. (Birmingham, […]
Read More